February 23rd Biotech Update

We are very close to breaking out.  I think it would be a nice way to end the week to get that initial breakout and run higher but there is actually not a lot of news that could drive it.  Rates expectations are a little less dovish with most now not expecting the first rate […]

February 8th Biotech Update

Still in the choppy sort of market but we are at least holding up.  I understand the annoyance that the broader market is doing well and the sector is really lagging from relative sense but when the sector runs it will make up a lot of this underperformance.  January was a massive month for follow […]

February 5th Biotech Update

I would not say that we are at the end of the chop for the sector but are probably closer to the end than the beginning.  I saw some notes that blamed the lack of rate cuts on the market but I am not sure that is the issue.  It is true that rates remain […]

November 1st Biotech Update

The best sign for the overall market was the reversal on a day in which the SMID space could have been hammered by the SRPT news.  The sector started lower but then recovered to end solidly green.  That is a strong signal as to the overall health of the sector.  That is not to say […]

October 25th Biotech Update

A bounce feels good but as had been the case it really means nothing unless we can break above the lower high (which in this case is around $72).  Every one of these bounces has the chance to do so but as you know my mantra has been that we are likely to see $62 […]

October 5th Biotech Update

Are we getting to a near term bottom in the sector?  Perhaps, the selling is getting to pretty extreme levels and we did not end yesterday on the lows.  We did not really do a massive reversal either, but I do not think we have a near-term chance of getting to the multi-year lows of […]

September 11th Biotech Update

Not a ton has changed.  We are setting up the potential to establish a higher low but that probably needs to be done this week and I still think there is a potential to revisit the lows as opposed to stay well above them.  As I noted last week, I sort of lean towards more […]

September 5th Biotech Update

I think we are finally out of the riskiest area and are setting up a potential to break the downtrend.  I think trading on Friday broke the clear downtrend, but we probably want to see more before declaring it over.  Of course, not having the downtrend is different than having an established uptrend.  It would […]

August 28th Biotech Update

Is my belief that we make our way to the 52-week lows before finding support to start a trend higher in threat?  Possibly.  Is it strange that I would think that on what looks like one good start to a week?  A little but I do think we have the potential to shift to a […]

July 26th Biotech Update

Not really an inspiring week for the sector so far.  The broader sector continues to muddle where we really need some excitement and momentum.  I still think we in potential trouble when the broader market corrects.  Perhaps we somehow get money when the broader market corrects but we generally go down even more when the […]

May 23rd Biotech Update

A nice little rally yesterday and hopefully we can continue that momentum.  Obviously the ideal scenario is that the sector can break out and go to a higher high after having set a higher low.  To be fair, we have been in this situation before and even had a mini upward trend established only to […]

May 18th Biotech Update

The FTC news with AMGN and HZNP was an awful way to start the week but in all honesty, the sector seems to have held up.  The green day yesterday could be setting up a higher low, which assumes we make a higher high.  I would not say the all clear has been signaled but […]

May 16th Biotech Update

The sector absolutely cannot catch a break.  Everything was looking good and solid and now the proverbial rug has been pulled out.  There is no recovering today.  It will be red but the broader move is not done (at least it does not have to be).  I think as long as this pullback stays above […]

May 9th Biotech Update

Overall the market seems to be digesting the recent moves, which is fine.  A day or two sitting around these levels before a push higher is probably better for the longer run potential of the next move.  As long as we keep making higher highs and higher lows, it remains a positive environment for the […]

April 28th Biotech Update

It is more than a little disheartening to see a strong rally that leaves out the sector.  If one wants to try and look at the bright side it saved us from breaking down and we seem to be bouncing off of a support level.  Of course, it looks pretty meaningless if we cannot rally […]

April 24th Biotech Update

A slow start to the week after a couple of bust Mondays with deals.  We are getting into earnings seasons and so it is not surprising that we slow as companies get ready to report.  I do not think there is anything that will be very compelling or thesis changing in earning and I suspect […]

April 17th Biotech Update

Last week I wanted to see a nice move above the $80 level on the XBI as a way to perhaps setup a little bull run.  It failed but today is certainly different.  The move today was sort of what I was looking for last week and we need to stay above the $80 level.  […]

March 15th Biotech Update

Not the best start to the day.  It seems like banks are taking a hit (and not just the regionals but even the too big to fail variety) and as long as the market perceives a banking crisis, it will be difficult for the market to rally.  To be fair when you have two of […]

February 1st Biotech Update

Yesterday was an interesting day.  I took a step back and looked at the chart and while you might think I am crazy, if you squint in the right way it looks like we have already broken out.  Maybe.  If we use $87 as the top of the range, then we broke above it on […]

January 30th Biotech Update

I feel like a broken record as we start yet another week with the potential to break out to the upside but not the best start in that attempt.  There is not a lot to cover today, so it will be quick but we do have earnings that could be an excuse for the move […]